Inactive Instrument

News Intervacc AB Nasdaq Stockholm

Equities

End-of-day quote Nasdaq Stockholm Other stock markets
- ^SEK	-

05-15	Intervacc AB Announces Board Appointments	CI
05-15	Intervacc AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Report from Annual General Meeting in Intervacc	05-15	AQ
Intervacc AB Announces Board Appointments	05-15	CI
Intervacc AB Reports Earnings Results for the First Quarter Ended March 31, 2024	05-15	CI
Notice of Annual General Meeting in Intervacc AB (publ)	04-15	AQ
Intervacc publishes the 2023 Annual Report	04-10	AQ
Intervacc announces changes in the Nomination Committee	03-04	AQ
Intervacc AB Announces Changes in the Nomination Committee	03-04	CI
Intervacc's Acting CEO Assumes Role Permanently	02-28	MT
Jonas Sohlman appointed as new CEO for Intervacc	02-28	AQ
Jonas Sohlman Appoints as New CEO for Intervacc AB	02-28	CI
Intervacc announces changes in dates for AGM and report for the first quarter 2024	02-22	AQ
Year-end report January - December 2023	02-16	AQ
Intervacc AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-16	CI
Intervacc AB Reports Earnings Results for the Full Year Ended December 31, 2023	02-16	CI
Invitation to conference call and audiocast in connection with the year-end report	02-13	AQ
Intervacc, Moredun Scientific Receive Eurostars Grant for Vaccine Against Pig Infection	02-08	MT
Intervacc awarded prestigious Eurostars grant to advance their new prototype vaccine against Streptococcus suis infection in pigs	02-07	AQ
Intervacc AB Awards Prestigious Eurostars Grant to Advance Their New Prototype Vaccine Against Streptococcus Suis Infection in Pigs	02-07	CI
Intervacc announces changes in the Nomination Committee	12-21	AQ
Intervacc AB Announces Changes in the Nomination Committee	12-21	CI

No results for this search